Table 2.
The number of goblet cells, villi height, crypt depth and villi/crypt ratio of control and treated groups
| Group | the number of goblet cells Mean ± SD | Villi height (mm) | Crypt depth (mm) | Villi/Crypt ratio |
|---|---|---|---|---|
| Non-infected non-treated (G I) | 8.22 ± 2.52 | 7.8±2.1 | 3.2±0.7 | 2.5±0.4 |
| Infected non-treated group (G II) | 8.55 ± 3.22 | 4.3±1.3* | 4±0.9 | 1.1±0.2* |
| Ginger 10 mg (G III) | 3.74 ± 1.50* | 5.2±1.3* | 4±0.7 | 1.3±0.3* |
| Ginger 20 mg (G IV) | 2.93 ± 2.20* | 5.2±1.2* | 3.2±0.5 | 1.6±0.4* |
| Cinnamon 10 mg (G V) | 10.81 ± 2.18 | 6.1±1.9 | 4.4±0.8* | 1.4±0.2* |
| Cinnamon 20 mg (G VI) | 5.36 ± 1.69 | 5.7±1.6 | 3.1±0.8 | 1.8±0.4* |
P-value represents the relationships between GI and all other groups. /
*
Significant at (P ≤0.05).